Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New shot every 6 months could slash asthma attacks
Disease control Recruiting nowThis study tests a new medicine called GB-0895 for people with severe asthma that is not controlled by standard inhalers. About 786 adults and teens aged 12 to 80 will get either GB-0895 or a placebo injection every 6 months for a year. The goal is to see if GB-0895 reduces the n…
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
New shot every 6 months could slash severe asthma attacks
Disease control Recruiting nowThis study tests a new medicine called GB-0895 for people aged 12 to 80 with severe asthma that is not controlled by standard inhalers. Participants will receive either GB-0895 or a placebo every 6 months for a year. The goal is to see if GB-0895 can reduce the number of serious …
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug aims to tame chemo side effects in bladder cancer patients
Symptom relief Recruiting nowThis early-phase study tests an investigational drug called GB-4362 in 37 adults with advanced bladder cancer who are already receiving standard treatments. The drug is designed to neutralize a chemotherapy byproduct that can cause nerve damage and other side effects. The main go…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC